Hospital acquired infections (HAIs) caused by viruses and bacteria are often talked about as being one of the major concerns in healthcare. The tentative expense of individuals infected by HAIs in the Indian healthcare sector, including CDIs, is around $4,611 per infected patient. [1] In events when patients suffering from HAIs need to be admitted to the intensive care unit, it can cost up to INR 2,23,155.81. [2] There is another threat that the world is facing, which calls for increased awareness- Infections caused by bacterial spores. Wondering what spores are? Gram-positive bacteria belonging to Bacillus spp. and Clostridium spp. are able to generate endospores as a survival mechanism.
Bacterial spores are considered the most dormant form of bacteria because they show minimum metabolism, respiration and enzyme production. Endospores are resistant to most chemical disinfectants, which makes it difficult to control such infections.
Some pathogenic species of Clostridioides difficile is formerly known as Clostridium difficile and often called C.difficile or more commonly C.diff are known to be the leading cause of nosocomial infections globally. Traditionally toxic chemical disinfectants are used to combat spores, but the downside is these harsh disinfectants can damage medical equipment, surfaces and harm human health.
C.difficile, also known as C.diff, is an obligate, anaerobic, spore-forming bacterium. C.diff infections (CDIs) are a severe healthcare problem, with increasing evidence of causing mortality and morbidity.
C.diff transmits spores through symptomatic and asymptomatic carriers to the environment or by means of healthcare professionals. In healthcare environments, the pathogen is commonly transmitted through hands of medical professionals. It spreads via direct and indirect contact, affecting the bowel, characterised by symptoms such as diarrhoea several times a day, fever, loss of appetite and stomach pain.
A hypervirulent strain/ribotype 027 of C.diff known as NAP1/B1/027 or North American pulse-field gel electrophoresis type 1 displays much more recurrence rate than its other strains. [3] It produces two toxins: enterotoxin A (Toxin A) and cytotoxin B (Toxin B) that determine the pathogenicity of the organism. Risk factors of a CDI mainly include prolonged exposure, healthcare settings, suppressant drugs and elemental diet. Since C.diff can survive in the environment for several months, it can re-activate upon contact with a vulnerable host.
Controlling CDIs poses a clinical challenge because the bacterial spores are resistant to most antibiotics and the infection often reoccurs. [4] C.diff spores possess the ability to survive in mono- or mixed-species biofilms. Infections by this pathogen can go out of control, emphasizing the need to manage them carefully. [5]
C.diff spores can be found on multiple surfaces across healthcare facilities if they are not disinfected properly with high-efficacy disinfectants.
80% of infections are spread by touch this means healthcare professionals, patients’ and visitors’ hands may frequently become contaminated with bacterial spores if good hand hygiene practice is not followed.[6]
For example, if a nurse caring for a patient with CDI does not perform proper hand hygiene practices after patient contact, it can increase the risk of transmission. [7]
Research evidence proved a significant positive correlation between hand sanitation and infection by C.diff spores. Maintaining hand hygiene is an essential component to prevent transmission of C.diff . Medical staff need to practice appropriate contact precautions, like using gloves, washing hands thoroughly with a broad-spectrum disinfectant and sanitise the environment. These combined with integrated surveillance programs can effectively control CDI outbreaks. [8]
Bioguard products are dermatologically tested, pH neutral to avoid skin irritation and are formulated with a non-sticky greasy formula. They are biochem-powered, a unique compound that makes all our disinfectants potent against C.diff.
|
|
Bioguard’s alcohol-free hand foam sanitiser and medical scrub simplify controlling CDIs. Unlike other alcohol products, these show high efficacy against C.diff.